Who owns the EVOXAC ORAL SOLUTION trademark?

The EVOXAC ORAL SOLUTION trademark is owned by Cosette Pharmaceuticals, Inc..

What class is the EVOXAC ORAL SOLUTION trademark registered in?

The EVOXAC ORAL SOLUTION trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for EVOXAC ORAL SOLUTION?

The USPTO serial number for EVOXAC ORAL SOLUTION is 99345341.

What is the registration number for EVOXAC ORAL SOLUTION?

EVOXAC ORAL SOLUTION is registered under USPTO registration number 0.

EVO

USPTO Trademark Record

PENDING

EVOXAC ORAL SOLUTION

SN 99345341·Reg 0·Filed Aug 19, 2025

Owner Cosette Pharmaceuticals, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

EVOXAC ORAL SOLUTION (Serial No. 99345341), Registration No. 0, is a pending US trademark filed on Aug 19, 2025 by Cosette Pharmaceuticals, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Statement of Use due: March 31, 2027152 days remaining

Mark Intelligence

EVOXAC ORAL SOLUTION (Reg. #0) is a pending US trademark that was filed in 2025 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Aug 19, 2025

SERIAL

99345341

REG#

Owner

Applicant

Cosette Pharmaceuticals, Inc.

Entity

Corporation

State

Address

200 Crossing Blvd., 4th Floor, Bridgewater, NJ, 08807

Country

Attorney

NameMark A. Mazza

Law firm

Mark A. Mazza Eckert Seamans Cherin & Mellott, LLC

Docket

500879-00302

Address

600 Grant Street, 44th Floor, Eckert Seamans Cherin and Mellott, LLC, Pittsburgh, PA 15219, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusPENDING

Filing DateAug 19, 2025

Serial Number99345341

Registration No.0

Status DateApr 29, 2026

Published for OppositionFeb 03, 2026

Mark TypeDesign with words

Attorney Docket500879-00302

Status DescriptionLive and pending, first extension granted

Filing Signals

FILED

2025

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

18 events

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 30, 2026

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Apr 29, 2026

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Apr 29, 2026

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Apr 29, 2026

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Mar 31, 2026

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Feb 03, 2026

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 03, 2026

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 28, 2026

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO EXAMINER

Jan 08, 2026

ASSIGNED TO EXAMINER

EXAMINERS AMENDMENT -WRITTEN

Jan 08, 2026

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Jan 08, 2026

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jan 08, 2026

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Jan 08, 2026

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 08, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 07, 2026

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NOTICE OF DESIGN SEARCH CODE E-MAILED

Jan 07, 2026

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION ENTERED

Aug 19, 2025

NEW APPLICATION ENTERED

APPLICATION FILING RECEIPT MAILED

Aug 19, 2025

APPLICATION FILING RECEIPT MAILED

EVOXAC ORAL SOLUTION

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Cosette Pharmaceuticals, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Mark A. Mazza

Industries

USPTO Deadlines

Compare

Resources

Company